The stock has broken out with good volumes and retested, so it may undergo a rally. Trade is supported by brokerage calls and Supports Nearby.
Risk Reward Ratio - 3:1
SL is placed below support zone & the previously upper & lower trendline. The target is placed based on fundamentals.
The stock has reached lower trendline and may undergo a reversal rally. Trade is supported by brokerage calls and Supports Nearby.
Risk Reward Ratio - 2:1
SL is placed below support zone & the lower trendline. The target is placed based on fundamentals and near all time high.
Beyond Air has continued a strong uptrend since June. Recently its bin tapering and has shown a symmetrical triangle formation. A Brake out to the upside is likely to continue the uptrend. Watch for a move past the top of the triangle at 11.88 level for conformation and more possible upside. No resistance till 12.50 a high not seen since March 4, 2020
Merck & Co., Inc., d.b.a. Merck Sharp & Dohme outside the United States and Canada, is an American multinational pharmaceutical company headquartered in Kenilworth, New Jersey. It is named after the Merck family, which set up Merck Group in Germany in 1668. Merck & Co. was established as an American affiliate in 1891
Entry on the bullish break of the dynamic...
NRXP is in for a wild & volatile ride where it may reverse & double in value or even more. Technicals support a reversal over weeks with a current strong trend on the daily.
Fundamentals are strong; F-Score is 9 & they just had some major news catalysts including a COVID-19 Treatment drug.
High risk with potentially high reward: up to a 25% drawdown and a...
A company with over 10 years of consistent and constant growth, a wide coverage of products already on the market and... despite an excellent quarterly for a news or a trail .. boom .. It drops suddenly ?
In my opinion this is sheer market madness, the sites I use as a reference for fundamental analysis confirm to me what I say, the company always be more than...
Bionano is a hyper-technological industry that operates at the level of the human genome.
It has developed a platform with an unprecedented ability to detect structural variations in DNA molecules, is active in research for the fight against cancer and other genetic diseases.
It presented excellent results days ago and now a category of big investors has started...
The weekend is a good time to scroll through the charts to find some gems for the coming week and for the coming month.
Cipla is one such stock that came on my radar this week, stock had seen a good move from 738 levels to 966 levels, comprising about 35% return in just 4 -5 weeks.
After seeing a remarkable rally, stock decided to correct, and I as a buyer could...
This stock closely followed the inverted head and should pattern and broke the neckline. The price target today was nearly short of 40 points if compared w/ neck to head distance which is still good. The stock also touched it's near high today.
It will be interesting to see where does stock head this. I am of the opinion that this will show a short term bearish...